Literature DB >> 25027056

The clinical significance of potentially curative resection for gastric cancer following the clearance of free cancer cells in the peritoneal cavity by induction chemotherapy.

Masaki Aizawa1, Atsushi Nashimoto, Hiroshi Yabusaki, Satoru Nakagawa, Atsushi Matsuki, Keiichi Homma, Takashi Kawasaki.   

Abstract

PURPOSE: The aim of this study was to evaluate the significance of the conversion of the peritoneal cytology from positive to negative following induction chemotherapy in relation to the prognosis after subsequent resection for gastric cancer.
METHODS: This retrospective study was conducted using a prospectively maintained database. A total of 47 patients with free cancer cells in the peritoneal cavity, as evaluated by staging laparoscopy, but no other evidence of distant metastasis, who underwent induction chemotherapy followed by surgery were enrolled in the study. Then, the clinicopathological factors and survival in the study subjects were assessed.
RESULTS: The median survival time and 5-year overall survival rate of the 47 study participants were 20.4 months and 25.0 %, respectively. In 23 of the patients, the peritoneal cytology converted from positive to negative after the induction chemotherapy, and a microscopically margin-negative gastrectomy was performed. The median survival time of 30.4 months and the 5-year survival rate of 34.6 % of these patients was significantly more favorable than the corresponding values of 15.0 months and 17.6 % in the patients who had persistently positive cytology (P = 0.03).
CONCLUSION: Based on our findings, the clearance of free cancer cells in the peritoneal cavity by induction chemotherapy improves the prognosis of patients following subsequent gastrectomy.

Entities:  

Mesh:

Year:  2014        PMID: 25027056     DOI: 10.1007/s00595-014-0979-0

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  20 in total

1.  New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

Authors:  P Therasse; S G Arbuck; E A Eisenhauer; J Wanders; R S Kaplan; L Rubinstein; J Verweij; M Van Glabbeke; A T van Oosterom; M C Christian; S G Gwyther
Journal:  J Natl Cancer Inst       Date:  2000-02-02       Impact factor: 13.506

2.  Long-term follow up of patients who were positive for peritoneal lavage cytology: final report from the CCOG0301 study.

Authors:  Yasuhiro Kodera; Seiji Ito; Yoshinari Mochizuki; Norifumi Ohashi; Chie Tanaka; Daisuke Kobayashi; Hiroshi Kojima; Takanori Matsui; Ken Kondo; Michitaka Fujiwara
Journal:  Gastric Cancer       Date:  2012-04-21       Impact factor: 7.370

3.  Laparoscopic staging for gastric cancer.

Authors:  A M Lowy; P F Mansfield; S D Leach; J Ajani
Journal:  Surgery       Date:  1996-06       Impact factor: 3.982

4.  Long-term results and prognostic factors of gastric cancer patients with only positive peritoneal lavage cytology.

Authors:  Cheong Ah Oh; Jae Moon Bae; Seung Jong Oh; Min Gew Choi; Jae Hyung Noh; Tae Sung Sohn; Sung Kim
Journal:  J Surg Oncol       Date:  2011-09-06       Impact factor: 3.454

5.  Japanese classification of gastric carcinoma: 3rd English edition.

Authors: 
Journal:  Gastric Cancer       Date:  2011-06       Impact factor: 7.370

6.  Peritoneal wash cytology in gastric carcinoma. Prognostic significance and therapeutic consequences.

Authors:  M La Torre; M Ferri; M R Giovagnoli; N Sforza; G Cosenza; E Giarnieri; V Ziparo
Journal:  Eur J Surg Oncol       Date:  2010-07-01       Impact factor: 4.424

7.  Prognostic significance of peritoneal washing cytology in patients with gastric cancer.

Authors:  S D Lee; K W Ryu; B W Eom; J H Lee; M C Kook; Y-W Kim
Journal:  Br J Surg       Date:  2011-11-18       Impact factor: 6.939

8.  Intraoperative lavage for cytological examination in 1,297 patients with gastric carcinoma.

Authors:  E Bando; Y Yonemura; Y Takeshita; K Taniguchi; T Yasui; Y Yoshimitsu; S Fushida; T Fujimura; G Nishimura; K Miwa
Journal:  Am J Surg       Date:  1999-09       Impact factor: 2.565

9.  The value of peritoneal cytology as a preoperative predictor in patients with gastric carcinoma undergoing a curative resection.

Authors:  David Bentrem; Andrew Wilton; Madhu Mazumdar; Murray Brennan; Daniel Coit
Journal:  Ann Surg Oncol       Date:  2005-03-31       Impact factor: 5.344

10.  Gastric cancer treatment in Japan: 2008 annual report of the JGCA nationwide registry.

Authors:  Yoh Isobe; Atsushi Nashimoto; Kohei Akazawa; Ichiro Oda; Kenichi Hayashi; Isao Miyashiro; Hitoshi Katai; Shunichi Tsujitani; Yasuhiro Kodera; Yasuyuki Seto; Michio Kaminishi
Journal:  Gastric Cancer       Date:  2011-09-07       Impact factor: 7.370

View more
  9 in total

1.  Conversion therapy for peritoneal lavage cytology-positive type 4 and large type 3 gastric cancer patients selected as candidates for R0 resection by diagnostic staging laparoscopy.

Authors:  Itaru Yasufuku; Souya Nunobe; Satoshi Ida; Koshi Kumagai; Manabu Ohashi; Naoki Hiki; Takeshi Sano
Journal:  Gastric Cancer       Date:  2019-07-26       Impact factor: 7.370

2.  Conversion therapy for gastric cancer: who can make conversion as successful as Goromaru?

Authors:  Masanori Terashima
Journal:  Gastric Cancer       Date:  2016-04-07       Impact factor: 7.370

3.  Feasibility of neoadjuvant S-1 and oxaliplatin followed by surgery for resectable advanced gastric adenocarcinoma.

Authors:  Yoshitaka Honma; Yasuhide Yamada; Tetsuji Terazawa; Atsuo Takashima; Satoru Iwasa; Ken Kato; Tetsuya Hamaguchi; Yasuhiro Shimada; Masaki Ohashi; Shinji Morita; Takeo Fukagawa; Nozomu Machida; Hitoshi Katai
Journal:  Surg Today       Date:  2015-11-13       Impact factor: 2.549

4.  Usefulness of diagnostic laparoscopy with 5-aminolevulinic acid (ALA)-mediated photodynamic diagnosis for the detection of peritoneal micrometastasis in advanced gastric cancer after chemotherapy.

Authors:  Kentaro Kishi; Yoshiyuki Fujiwara; Masahiko Yano; Masaaki Motoori; Keijiro Sugimura; Hidenori Takahashi; Masayuki Ohue; Masato Sakon
Journal:  Surg Today       Date:  2016-03-23       Impact factor: 2.549

Review 5.  Current status of conversion surgery for stage IV gastric cancer.

Authors:  Jun Kinoshita; Takahisa Yamaguchi; Hideki Moriyama; Sachio Fushida
Journal:  Surg Today       Date:  2021-01-23       Impact factor: 2.549

Review 6.  Prognostic significance of peritoneal lavage cytology in staging gastric cancer: systematic review and meta-analysis.

Authors:  Sara Jamel; Sheraz R Markar; George Malietzis; Amish Acharya; Thanos Athanasiou; George B Hanna
Journal:  Gastric Cancer       Date:  2017-08-04       Impact factor: 7.370

7.  Overexpression of leucine-rich α2-glycoprotein-1 is a prognostic marker and enhances tumor migration in gastric cancer.

Authors:  Masaaki Yamamoto; Tsuyoshi Takahashi; Satoshi Serada; Takahito Sugase; Koji Tanaka; Yasuhiro Miyazaki; Tomoki Makino; Yukinori Kurokawa; Makoto Yamasaki; Kiyokazu Nakajima; Shuji Takiguchi; Testsuji Naka; Masaki Mori; Yuichiro Doki
Journal:  Cancer Sci       Date:  2017-10       Impact factor: 6.716

Review 8.  Free intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and meta-analysis.

Authors:  Mathieu Pecqueux; Johannes Fritzmann; Mariam Adamu; Kristian Thorlund; Christoph Kahlert; Christoph Reißfelder; Jürgen Weitz; Nuh N Rahbari
Journal:  Oncotarget       Date:  2015-11-03

9.  Optimizing outcomes for patients with gastric cancer peritoneal carcinomatosis.

Authors:  Jennifer L Leiting; Travis E Grotz
Journal:  World J Gastrointest Oncol       Date:  2018-10-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.